Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Guide7 min read

Medvi Cost 2026: What $99/Month Actually Buys You

Medvi charges $99/month promo (reg. $199) for semaglutide and $166 (reg. $299) for tirzepatide, all-inclusive GLP-1 care. The full math and when a rival wins.

Updated September 15, 2026

Medically reviewed on

How we review

Key takeaways

  • Medvi costs $99/month for compounded semaglutide (promo, regularly $199) or $166/month for tirzepatide (regularly $299) - all-inclusive.
  • That one price covers the medication, provider consultations, monitoring, a dietician with care coaching, and free shipping; HSA/FSA accepted, no dose-based increases.
  • A year runs $1,188 on semaglutide or $1,992 on tirzepatide at the promo rates.
  • The same semaglutide runs $41-$125 at welludr, embody and HealthRx; Medvi's premium buys the human support layer, worth it only if support determines your success.

The two numbers, and what “all-inclusive” covers

The short answerMedvi currently costs $99/month for compounded semaglutide (a promotional rate - regularly $199) or $166/month for compounded tirzepatide (regularly $299). That single number covers the medication, provider consultations, regular monitoring, a dietician with care coaching, and free shipping - no membership fee, no dose-based increases, no checkout surprises. HSA/FSA funds are accepted.

The bundling is the point. At providers that price à la carte, the advertised medication price is the beginning of the bill, not the end of it. Medvi's price is the end of it - which makes it one of the easiest bills in this market to actually budget for.

A year on Medvi: the honest math

Nobody should start a GLP-1 for one month - clinically meaningful results build over months, with dose titration along the way (see what the first month really looks like). So price it like what it is, a recurring commitment:

TimelineSemaglutide ($99/mo promo)Tirzepatide ($166/mo promo)
3 months$297$498
6 months$594$996
12 months$1,188$1,992

Two things make that math kinder than it looks. Dose increases are already priced in - many rivals charge more as you titrate up, Medvi doesn't. And HSA/FSA eligibility means those figures can effectively shrink by your marginal tax rate if you pay with pre-tax dollars. The tirzepatide plan has its own breakdown in our Medvi tirzepatide cost guide.

What Reddit says about Medvi

Excerpts from real public Reddit posts and comments - the strengths and the caveats, in users’ own words.

r/r/telehealth·u/marlsygarlsy·6mo agoabout Medvi

Topic: Results / clinician access / cost

Medvi GLP-1 telehealth experience breakdown

“Within a few days, I heard back from a licensed provider... Most of the communication happened through secure messaging.”

“I did have some mild nausea when my dose increased, but it was manageable and improved after a short time... Around the middle of the year, progress slowed and I hit a plateau. I reached out through the messaging system, and my provider adjusted my dose, which helped me start moving again.”

u/Canadian_Insulin

“Clinically speaking, losing around 10 to 15 percent of starting body weight over a year is very much within the expected and healthy range for semaglutide treatment.”

r/r/productreview·u/External-Neck-7278·6mo agoabout Medvi

Topic: Results over a full year

My 2026 MEDVI review after using it for a full year

“The first thing I noticed was that my appetite felt different in a calm manageable way rather than feeling like I was constantly fighting hunger.”

“Over the course of the year I lost just over 40 pounds and more importantly I've been able to maintain that loss without feeling burnt out.”

u/Decent_Feature_9060

“medvi is the best triz provider i ever had (changed 3 providers so far)”

Excerpts from public Reddit posts, lightly trimmed; vote and comment counts shown as captured at the time of review. Posts are individual experiences, and any weight-loss result mentioned is one person’s and is not typical - results vary. Reddit is a trademark of Reddit, Inc. and is not affiliated with this site.

Shop GLP-1 plans by product

The lowest published plans - cheapest first, conditions under each price.

How does Medvi's $99 compare to other providers?

Against the rest of our ranking, at each provider's real listed prices:

ProviderSemaglutideTirzepatidePricing model
welludr$41/mo$71/mo12-month lock for best rate
embody$49/mo$99/moFlat monthly, no commitment
altRx$89/mo$149/moFlat at every dose, BNPL
HealthRx$125/mo$199/moMonthly plan, $39 first month
DirectMeds$249/mo (sublingual)Not publishedNeedle-free option; injections $297
Medvi$99/mo promo (reg. $199)$166/mo promo (reg. $299)Monthly all-inclusive + coaching
SHED$199/mo$299/moCoaching + money-back guarantee

At its regular $199/$299 rates Medvi prices near the top of the compounded market - but the current $99/$166 promotion drops it into the value tier while keeping the bundle. The fair question is what the premium (if any) buys. The answer is the human layer: video visits, a dietician and care coaching. Nobody in the cheaper tier bundles that.

Is Medvi worth it?

Worth it: if support determines whether you succeed. If you've tried medication-only approaches and stalled, if you want a provider who takes the call rather than an inbox, if a dietician guiding your food changes sounds like the missing piece - that's Medvi's actual product, and its review record says it delivers.

Not worth it: if you're self-directed and price-sensitive. The same semaglutide runs $41-$125 at welludr, embody and HealthRx; over a year the gap is four figures. The medication doesn't know what you paid for it - the difference is entirely in the care around it.

→ The closest call: HealthRx's $125 monthly plan vs Medvi's $99 promo, compared

This article is general information, not medical advice. Prices as listed at the time of writing - confirm current pricing on each provider's site.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)